Determinants of biological drug survival in rheumatoid arthritis: evidence from a Hungarian rheumatology center over 8 years of retrospective data

OBJECTIVE: To compare drug survival of biological therapies in patients with rheumatoid arthritis (RA), and analyze the determinants of discontinuation probabilities and switches to other biological therapies. MATERIALS AND METHODS: Consecutive RA patients initiating first biological treatment in on...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Clinicoecon Outcomes Res
Autori principali: Brodszky, Valentin, Bíró, Anikó, Szekanecz, Zoltán, Soós, Boglárka, Baji, Petra, Rencz, Fanni, Tóthfalusi, László, Gulácsi, László, Péntek, Márta
Natura: Artigo
Lingua:Inglês
Pubblicazione: Dove Medical Press 2017
Soggetti:
Original Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5317255/
https://ncbi.nlm.nih.gov/pubmed/28243133
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CEOR.S124381
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi